Work

Inhibition of the PI3K/Akt/mTOR pathway abrogates laminin-mediated SCLC survival and resistance to Gleevec

Year: 2004

Type: article

Source: Cancer Research

Authors: Junji Tsurutani, Kip A. West, Jacqueline Sayyah, Phillip A. Dennis

Institution: National Cancer Institute

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1571683217

FWCI:

Cites:

Cited by:

Related to: 10